Cooperative Agreement U62PS023343

This $11,097,080 Cooperative Agreement award from the U.S. Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) supports efforts to build and improve integrated laboratory capacity and quality services for HIV testing, treatment, and care in the Democratic Republic of the Congo (DRC). The award recipient, Global Health Systems Solutions (GHSS), will work to scale up quality assurance and improvement for HIV rapid testing and other diagnostic services,...

The National Institutes of Health (NIH) Fogarty International Center (CFDA 93.989) awarded a $201,215 Project Grant to the Institut National De Recherche Biomedicale (INRB) in Kinshasa, Democratic Republic of the Congo. The grant, titled "Emerging and Re-Emerging Pathogens Research Training Program in DRC (EREP-RTP-DRC)," aims to build a critical mass of next-generation basic, translational, clinical, and public health scientists capable of responding to emerging and re-emerging...

The Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) awarded a $6,749,031 Cooperative Agreement under the Global AIDS Federal Grant Program (CFDA 93.067) to the Association De Sante Familiale, a local non-profit organization in the Democratic Republic of the Congo (DRC), and PATH, a U.S.-based international NGO. The award, titled the "USHINDI Project", aims to enhance access to HIV services and achieve epidemic control in seven health zones...

This federal Cooperative Agreement award, with a total funding amount of $300,000.00, was granted by the Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067). The award supports the "TOTAL CONTROL OF THE EPIDEMIC TCE KINSHASA" project, which aims to combat HIV/AIDS in the Democratic Republic of the Congo. The primary awardee, Humana People To People Congo, will provide technical assistance, capacity building, and direct service delivery to...

This federal Cooperative Agreement award of $820,000.00 was granted by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283). The award is titled "STRENGTHENING ROUTINE IMMUNIZATION AND VACCINE EQUITY (STRIVE) IN THE DEMOCRATIC REPUBLIC OF THE CONGO AND BRAZIL" and is intended to support public health initiatives focused on improving disease surveillance, enhancing laboratory capacity, and strengthening health...

The Department of State Bureau of International Security and Nonproliferation awarded a $175,423 cooperative agreement to CRDF Global to enhance physical security measures at a high containment laboratory in Kinshasa, Democratic Republic of the Congo from June 2022 through December 2023. The funding supports the Global Threat Reduction program, which aims to reduce biological threats through securing vulnerable high-containment pathogen stocks. Specifically, the award will enhance physical...

This $100,000 Project Grant awarded on June 3, 2024 by the U.S. Department of State Bureau of African Affairs under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) Program (CFDA 19.029) will support community-led monitoring to improve healthcare services in Kinshasa, Democratic Republic of the Congo. The prime awardee, Miscellaneous Foreign Awardees (doing business as Federal Egov IAE Initiative - Generic Entity Identifier), will utilize the funding over the 12-month period...

This $2,777,976 Cooperative Agreement awarded by the U.S. Agency for International Development (USAID) under the "USAID Foreign Assistance for Programs Overseas" (CFDA 98.001) program aims to improve the HIV response and ensure sustained epidemic control in the Haut-Katanga province of the Democratic Republic of the Congo (DRC). The prime awardee, Family Health International (FHI 360), will implement activities to decrease new HIV infections and HIV-associated morbidity and...

The Department of State Bureau of International Security and Nonproliferation awarded a $144,967 cooperative agreement to Soter Bioconsulting under the Global Threat Reduction program (CFDA 19.033) to support developing high containment laboratory operations and maintenance plans and procedures in Kinshasa, Democratic Republic of Congo from October 1, 2022 through December 31, 2023. As part of the Global Threat Reduction program's efforts to reduce biological threats, this cooperative...

This federal Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283) provides $1,770,000.00 in funding to ICF Macro Inc. to support "Advancing Diagnostic Network Optimization, Stepwise Laboratory Accreditation, and Integrated One Health Specimen Transport in Liberia." The 5-year project, running from September 30, 2024 to September 29, 2029, aims to strengthen Liberia's public...